Classification, epidemiology and clinical subgrouping of antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis.
about
The Prevalence and Management of Pauci-Immune Glomerulonephritis and Vasculitis in Western CountriesANCA-associated vasculitis in childhood: recent advances.Pauci-Immune Crescentic Glomerulonephritis in Connective Tissue Disease.Diagnosing ANCA-associated vasculitis in ANCA positive patients: A retrospective analysis on the role of clinical symptoms and the ANCA titre.Multicolor flow cytometric analysis of TLR2 and TLR9 expression and function in NK cells from patients with ANCA-associated vasculitis.Development and validation of case-finding algorithms for the identification of patients with anti-neutrophil cytoplasmic antibody-associated vasculitis in large healthcare administrative databases.Therapy and prognosis of ANCA-associated vasculitis from the clinical nephrologist's perspective.Clinical trials in antineutrophil cytoplasmic antibody-associated vasculitis: what we have learnt so far, and what we still have to learn.Cutaneous Manifestations of ANCA-Associated Small Vessels Vasculitis.The epidemiology of ANCA associated vasculitis in Olmsted County, Minnesota (USA): a 20 year population-based study.Incidence of ANCA-associated vasculitis in a UK mixed ethnicity population.The global burden of anti-neutrophil cytoplasmic antibody vasculitis: High but unquantified.Patients double-seropositive for ANCA and anti-GBM antibodies have varied renal survival, frequency of relapse, and outcomes compared to single-seropositive patients.ANCA-associated vasculitis predominantly presenting with severe myalgiasMPO-ANCA associated vasculitis with mononeuritis multiplex following influenza vaccination.Interstitial lung disease in systemic autoimmune rheumatic diseases: a comprehensive review.Stress and Disease Onset in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis.Anti-neutrophil cytoplasmic antibody-associated vasculitis: prevalence, treatment, and outcomes.The PTPN22 R620W polymorphism in anti-neutrophil cytoplasmic antibody-associated vasculitis in Mexican Mestizos.Improving Mortality in End-Stage Renal Disease due to Granulomatosis with Polyangiitis from 1995 to 2014.Update on Vertigo in Autoimmune Disorders, from Diagnosis to TreatmentPrimary Vasculitis in Childhood: GPA and MPA in Childhood
P2860
Q26740451-D81CFD30-887F-4D32-B5F6-408CB058047AQ33644574-3E246923-D1B6-40F8-A7BF-31BC3FC8A055Q37140687-F10EC8C8-800B-4525-97BD-9D97C77F1133Q37328955-DC3DDA57-35D0-48A8-BDFD-A15926C6B4DBQ38611714-A0D18CCB-B138-4F24-A6A8-02E8B1AF0A4AQ38800510-D30C7CC9-C87C-44A6-A7E5-2B2B46DE3053Q38965278-FEEA7EFD-47EB-4EF0-95A4-CF445EFE53AEQ39088103-E4CBCD1A-13CA-438F-8F3C-BBC96D8120D6Q39348719-D8D7B807-6916-40E8-9924-0E9079BFB9EFQ40053425-D5E2EE65-D2D3-4E32-8B7C-70992629A6ECQ40380718-1624E60A-2C4D-4399-82A3-4B6C2681ACFDQ40417170-7C530847-1C07-4D86-9808-9AD20634D347Q41491056-583256B2-7D37-44B1-89B7-94B0C10E6559Q42198437-753EF9AD-D4DB-4986-85E2-6B3243C2519CQ47150723-2C01161E-9372-484D-9C09-B52C973ACFFFQ47372819-1005A8DD-A2D7-4BC8-8687-2E4EF32AF67DQ47552876-7912DA04-6466-4C0D-BD81-D04C01F157D4Q49691317-C297AF47-F459-4BA5-8B9A-2A6C61C35166Q50142604-8F86B226-41C5-47F0-9A2C-E4B1405DCF7BQ54283470-1ABE93D8-6F05-41C2-8526-4297C19B5CFCQ57821296-CE077D33-54CD-4576-9AC4-1E8D5AB7A757Q58773547-A6D3A5B2-D3B2-4491-8614-B7C71BF2F049
P2860
Classification, epidemiology and clinical subgrouping of antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Classification, epidemiology a ...... (ANCA)-associated vasculitis.
@en
type
label
Classification, epidemiology a ...... (ANCA)-associated vasculitis.
@en
prefLabel
Classification, epidemiology a ...... (ANCA)-associated vasculitis.
@en
P2093
P2860
P356
P1476
Classification, epidemiology a ...... y (ANCA)-associated vasculitis
@en
P2093
Aladdin J Mohammad
Luis Felipe Flores-Suárez
Paul Gatenby
Richard A Watts
P2860
P304
P356
10.1093/NDT/GFV022
P407
P478
30 Suppl 1
P577
2015-04-01T00:00:00Z